기관지폐이형성증을 가진 미숙아 환아에서 하기도 호흡기 감염의 임상 양상 = Clinical characteristics of lower respiratory infections in preterm children with bronchopulmonary dysplasia

다국어 초록 (Multilingual Abstract)

Purpose: We evaluated the clinical characteristics of lower respiratory infections of preterm children with bronchopulmonary dysplasia (BPD) and compared them between those with and without lower respiratory infections that of preterm patients without BPD. Methods: This study enrolled preterm patients under 2 years old, who admitted with acute lower respiratory infection from March 2014 to May 2016. The patients were divided into 2 groups according to BPD, and we retrospectively reviewed their medical records. Results: A total of 71 patients (106 cases) were enrolled; the BPD group consisited of 29 patients (54 cases) and the control group 42 patients (52 cases). Compared to the patients in the control group, those in the BPD group were older (P=0.001), had lower gestational age and birth weight (P<0.001), and showed more frequent readmission in hospital (P=0.017). The most common causative virus was human rhinovirus (hRV) in the BPD group, whereas respiratory syncytial virus (RSV) in the control group. The patients in the BPD group showed a higher incidence of tachypnea, decreased aeration, and chest retraction (P<0.001, P=0.009, and P=0.026, respectively), a higher respiratory symptom score (P=0.011), a longer duration of cough and wheezy sounds (P=0.004 and P=0.009, respectively), and higher incidence and longer duration of treatment with oxygen, and mechanical ventilator support (P=0.016 and P=0.017, respectively) than those in the control group. In the BPD group, the patients with RSV showed a higher incidence of tachypnea and rales (P=0.033 and P=0.033, respectively) than those with hRV. Conclusion: The preterm children with BPD may have more severe clinical manifestations than those without. (Allergy Asthma Respir Dis 2017:5:92-98)

참고문헌 (Reference)

1 김진규, "Trends in Survival and Incidence of Bronchopulmonary Dysplasia in Extremely Preterm Infants at 23-26 Weeks Gestation" 대한의학회 31 (31): 423-429, 2016

2 Grimaldi M, "Severe respiratory syncytial virus bronchiolitis: epidemiologic variations associated with the initiation of palivizumab in severely premature infants with bronchopulmonary dysplasia" 23 : 1081-1085, 2004

3 Aujard Y, "Risk factors for severe respiratory syncytial virus infection in infants" 96 (96): S9-S14, 2002

4 Lee JH, "Respiratory syncytial virus related readmission in preterm infants less than 34 weeks' gestation following discharge from a neonatal intensive care unit in Korea" 30 (30): S104-S110, 2015

5 Pavón D, "Relation between pulse oximetry and clinical score in children with acute wheezing less than 24 months of age" 27 : 423-427, 1999

6 Carbonell-Estrany X, "Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group" 19 : 592-597, 2000

7 Resch B, "Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age" 50 : 397-403, 2005

8 Bhandari A, "Pulmonary outcomes in bronchopulmonary dysplasia" 30 : 219-226, 2006

9 Northway WH Jr, "Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia" 276 : 357-368, 1967

10 Coalson JJ, "Pathology of bronchopulmonary dysplasia" 30 : 179-184, 2006

11 "Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group" 102 (102): 531-537, 1998

12 최창원, "Incidence of Bronchopulmonary Dysplasia in Korea" 대한의학회 27 (27): 914-921, 2012

13 Lee HJ, "Immunization guideline" Korean Pediatric Society 231-233, 2012

14 Miller EK, "Human rhinoviruses in severe respiratory disease in very low birth weight infants" 129 : e60-e67, 2012

15 Furman L, "Hospitalization as a measure of morbidity among very low birth weight infants with chronic lung disease" 128 : 447-452, 1996

16 Park HW, "Epidemiology of respiratory syncytial virus infection in infants born at less than thirty-five weeks of gestational age" 31 : e99-e104, 2012

17 Hervás D, "Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis" 31 : 1975-1981, 2012

18 Pedraz C, "Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants" 22 : 823-827, 2003

19 Tal A, "Dexamethasone and salbutamol in the treatment of acute wheezing in infants" 71 : 13-18, 1983

20 García-Garcia ML, "Clinical and virological characteristics of early and moderate preterm infants readmitted with viral respiratory infections" 34 : 693-699, 2015

21 Jobe AH, "Bronchopulmonary dysplasia" 163 : 1723-1729, 2001

22 Morris SK, "A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection" 9 : 106-, 2009